VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
PDEXPro-Dex, Inc.
$63.39$203M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. PDEX
  3. Financial Ratios

Pro-Dex, Inc. (PDEX) Financial Ratios

30 years of historical data (1996–2025) · Healthcare · Medical - Instruments & Supplies

View Quarterly Ratios →

P/E Ratio
↓
23.74
+20% vs avg
5yr avg: 19.82
062%ile100
30Y Low2.6·High88.4
View P/E History →
EV/EBITDA
↓
18.39
↑+28% vs avg
5yr avg: 14.33
086%ile100
30Y Low0.8·High23.2
P/FCF
↓
N/A
—
5yr avg: 14.46
30Y Low2.0·High177.1
P/B Ratio
↓
5.82
↑+87% vs avg
5yr avg: 3.11
0100%ile100
30Y Low0.4·High4.7
ROE
↑
26.6%
↓+37% vs avg
5yr avg: 19.4%
083%ile100
30Y Low-103%·High45%
Debt/EBITDA
↓
1.39
↓-35% vs avg
5yr avg: 2.14
045%ile100
30Y Low0.0·High6.0

Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.

PDEX Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

Pro-Dex, Inc. trades at 23.7x earnings, 20% above its 5-year average of 19.8x, sitting at the 62nd percentile of its historical range. Compared to the Healthcare sector median P/E of 22.0x, the stock trades at a premium of 8%.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$203M$147M$70M$69M$60M$120M$73M$56M$29M$25M$23M
Enterprise Value$219M$163M$81M$81M$75M$135M$73M$53M$24M$21M$21M
P/E Ratio →23.7416.3432.739.7913.1827.0411.8813.3817.974.9227.80
P/S Ratio3.052.201.301.511.432.862.092.051.291.141.15
P/B Ratio5.824.002.272.202.364.733.813.281.671.832.61
P/FCF——13.4515.48——13.6328.9413.369.66177.14
P/OCF——11.3112.72——12.3216.779.337.7549.80

P/E links to full P/E history page with 30-year chart

PDEX EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

Pro-Dex, Inc.'s enterprise value stands at 18.4x EBITDA, 28% above its 5-year average of 14.3x. The Healthcare sector median is 14.1x, placing the stock at a 30% premium on an enterprise-value basis.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—2.451.511.761.793.222.101.941.060.961.04
EV / EBITDA18.3913.659.7312.2912.8523.159.549.688.056.3818.59
EV / EBIT20.5212.6425.398.1612.2021.999.0010.546.977.3718.01
EV / FCF——15.5418.12——13.7427.2910.988.08160.18

PDEX Profitability

Margins and return-on-capital ratios measuring operating efficiency

Pro-Dex, Inc. earns an operating margin of 16.1%. Operating margins have expanded from 12.5% to 16.1% over the past 3 years, signaling improving operational efficiency. ROE of 26.6% indicates solid capital efficiency. ROIC of 17.0% represents solid returns on invested capital.

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin29.3%29.3%27.0%27.7%31.2%31.2%37.7%36.0%35.4%32.7%26.8%
Operating Margin16.1%16.1%13.3%12.5%12.2%12.2%20.3%18.4%10.6%12.5%2.6%
Net Profit Margin13.5%13.5%4.0%15.3%10.9%10.9%17.5%15.3%7.2%23.2%4.1%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE26.6%26.6%6.8%24.8%18.0%20.6%33.9%24.2%10.5%45.0%9.5%
ROA15.8%15.8%4.1%14.0%9.3%11.4%21.6%18.3%8.9%37.0%6.9%
ROIC17.0%17.0%12.6%10.3%9.5%12.8%31.7%28.9%16.5%25.2%5.4%
ROCE24.8%24.8%17.6%14.4%13.6%16.1%30.0%25.9%15.4%23.9%5.9%

PDEX Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

Pro-Dex, Inc. carries a Debt/EBITDA ratio of 1.4x, which is manageable (57% below the sector average of 3.2x). Net debt stands at $16M ($17M total debt minus $419000 cash). Interest coverage of 15.5x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.450.450.440.470.630.630.370.270.000.010.01
Debt / EBITDA1.391.391.632.232.732.730.910.840.010.040.06
Net Debt / Equity—0.440.350.380.590.590.03-0.19-0.30-0.30-0.25
Net Debt / EBITDA1.351.351.311.792.582.580.08-0.59-1.75-1.24-1.97
Debt / FCF——2.092.64——0.11-1.65-2.38-1.57-16.96
Interest Coverage15.5515.555.7218.6913.2717.4934.4822.69486.43237.2531.49

PDEX Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

Pro-Dex, Inc.'s current ratio of 3.23x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 1.71x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio3.233.232.843.202.742.744.345.106.404.624.44
Quick Ratio1.711.711.661.531.631.632.763.644.673.422.72
Cash Ratio0.490.490.530.420.140.141.722.432.921.911.10
Asset Turnover—1.091.030.890.860.861.121.061.131.341.81
Inventory Turnover2.122.122.572.062.282.282.632.793.314.784.13
Days Sales Outstanding—95.8694.1478.82133.56133.5654.0255.0867.1260.2853.94

PDEX Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Pro-Dex, Inc. returns 1.7% to shareholders annually primarily through share buybacks. The earnings yield of 4.2% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————0.0%———
Payout Ratio———————0.6%———

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield4.2%6.1%3.1%10.2%7.6%3.7%8.4%7.5%5.6%20.3%3.6%
FCF Yield——7.4%6.5%——7.3%3.5%7.5%10.4%0.6%
Buyback Yield1.7%2.4%5.0%2.2%2.7%4.6%4.7%7.1%0.8%1.2%2.0%
Total Shareholder Yield1.7%2.4%5.0%2.2%2.7%4.6%4.7%7.2%0.8%1.2%2.0%
Shares Outstanding—$3M$4M$4M$4M$4M$4M$4M$4M$4M$4M

Peer Comparison

Compare PDEX with 10 similar companies in its peer group

CompanyMarket CapP/EEV/EBITDAP/FCFGross MarginOp MarginROEROICDebt/EBITDA
PDEX logoPDEXYou$203M23.718.4—29.3%16.1%26.6%17.0%1.4
NSYS logoNSYS$47M-185.024.122.515.2%1.0%-0.7%1.9%6.2
LIQT logoLIQT$9M-1.0——7.6%-50.3%-63.1%-31.0%—
ATRC logoATRC$1B-118.579.629.874.4%-0.6%-2.4%-0.6%5.2
MMSI logoMMSI$4B31.614.018.648.7%12.2%8.7%7.2%2.8
NVCR logoNVCR$2B-11.6——74.5%-23.5%-38.9%-16.4%—
OSIS logoOSIS$4B24.715.863.334.3%12.7%16.5%11.5%2.6
SYK logoSYK$119B36.921.627.764.0%19.5%15.1%11.1%2.7
ZBH logoZBH$17B24.79.811.661.6%16.5%5.6%5.4%3.1
MDT logoMDT$104B21.613.719.165.0%17.8%9.8%6.4%3.0
HOLX logoHOLX$17B30.517.418.461.0%17.4%11.1%9.4%2.6
Healthcare Median—22.014.118.763.6%-4.8%-32.4%-11.2%3.2

Peer selection based on competitive and market overlap. Compare multiple stocks →

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PDEX — Frequently Asked Questions

Quick answers to the most common questions about buying PDEX stock.

What is Pro-Dex, Inc.'s P/E ratio?

Pro-Dex, Inc.'s current P/E ratio is 23.7x. The historical average is 22.8x. This places it at the 62th percentile of its historical range.

What is Pro-Dex, Inc.'s EV/EBITDA?

Pro-Dex, Inc.'s current EV/EBITDA is 18.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 11.7x.

What is Pro-Dex, Inc.'s ROE?

Pro-Dex, Inc.'s return on equity (ROE) is 26.6%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 5.1%.

Is PDEX stock overvalued?

Based on historical data, Pro-Dex, Inc. is trading at a P/E of 23.7x. This is at the 62th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are Pro-Dex, Inc.'s profit margins?

Pro-Dex, Inc. has 29.3% gross margin and 16.1% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does Pro-Dex, Inc. have?

Pro-Dex, Inc.'s Debt/EBITDA ratio is 1.4x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.